Cristina Núñez

Prof. Cristina Núñez

Pharmacology, University of Murcia, Murcia, Spain
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2007 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Cristina NúñezCristina Núñez
Cristina Núñez
AFAnna Földes
Anna Földes
MLM. Luisa Laorden
M. Luisa Laorden
MMMaría Victoria Milanés
María Victoria Milanés
KKKrisztina J Kovács
Krisztina J Kovács
Morphine withdrawal results in serious affective and somatic symptoms including activation of the hypothalamo–pituitary–adrenocortical (HPA) axis. To reveal secretory, activational and transcriptional changes in the hypothalamus of morphine‐dependent rats during naloxone precipitated opioid withdrawal, we measured corticosterone secretion, c‐Fos induction and heteronuclear (hn)RNA levels of corticotropin‐releasing hormone (CRH) and arginine vasopressin (AVP) in naïve and morphine dependent animals injected with saline or 5 mg/kg naloxone. Naloxone precipitated morphine withdrawal resulted in a significant increase in corticosterone secretion and induction of neuronal activation in the hypothalamic paraventricular nucleus (PVH) 2 h after challenge. Using probes complementary to intronic sequences of genes encoding neuropeptides in parvocellular neurosecretory neurons of the PVH, we found robust increases in CRH and AVP hnRNAs in morphine dependent rats during naloxone precipitated withdrawal. Naïve rats and animals that were implanted with morphine pellets for 8 days did not display significant up‐regulation of ongoing neuropeptide expression in the parvocellular compartment of the PVH. In addition to hypophyseotropic neurons, naloxone precipitated withdrawal resulted in a marked activation in autonomic‐related projection neurons in PVH and in the magnocellular neurons in the PVH and supraoptic nuclei. These activations however were not associated with induction of CRH or AVP hnRNAs.

1 May 2010 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
JNJavier Navarro-Zaragoza
Javier Navarro-Zaragoza
Cristina NúñezCristina Núñez
Cristina Núñez
MLM. Luisa Laorden
M. Luisa Laorden
MMMaría Victoria Milanés
María Victoria Milanés
The role of stress in drug addiction is well established. The negative affective states of withdrawal most probably involve recruitment of brain stress neurocircuitry [e.g., induction of hypothalamo-pituitary-adrenocortical (HPA) axis, noradrenergic activity, and corticotropin-releasing factor (CRF) activity]. The present study investigated t$he role of CRF receptor-1 subtype (CRF1R) on the response of brain stress system to morphine withdrawal. The effects of naloxone-precipitated morphine withdrawal on noradrenaline (NA) turnover in the paraventricular nucleus (PVN), HPA axis activity, signs of withdrawal, and c-Fos expression were measured in rats pretreated with vehicle, CP-154526 [N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[3,2-e]pyrimidin-4-amine], or antalarmin (selective CRF1R antagonists). Tyrosine hydroxylase-positive neurons expressing CRF1R were seen at the level of the nucleus tractus solitarius-A2 cell group in both control and morphine-withdrawn rats. CP-154526 and antalarmin attenuated the increases in body weight loss and irritability that were seen during naloxone-induced morphine withdrawal. Pretreatment with CRF1R antagonists resulted in no significant modification of the increased NA turnover at PVN, plasma corticosterone levels, or c-Fos expression that was seen during naloxone-induced morphine withdrawal. However, blockade of CRF1R significantly reduced morphine withdrawal-induced increases in plasma adrenocorticotropin levels. These results suggest that the CRF1R subtype may be involved in the behavioral and somatic signs and in adrenocorticotropin release (partially) during morphine withdrawal. However, CRF1R activation may not contribute to the functional interaction between NA and CRF systems in mediating morphine withdrawal-activation of brain stress neurocircuitry.

2 May 2017 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
SMSandra Montagud-Romero
Sandra Montagud-Romero
Cristina NúñezCristina Núñez
Cristina Núñez
MBM.Carmen Blanco-Gandia
M.Carmen Blanco-Gandia
EMElena Martínez-Laorden
Elena Martínez-Laorden
MAMaria A Aguilar
Maria A Aguilar
MRMarta Rodríguez-Arias
Marta Rodríguez-Arias

18 September 2002 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
MLM. Luisa Laorden
M. Luisa Laorden
Cristina NúñezCristina Núñez
Cristina Núñez
PAPilar Almela
Pilar Almela
MMMaría Victoria Milanés
María Victoria Milanés

9 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLM. Luisa Laorden
M. Luisa Laorden
SFSzilamér Ferenczi
Szilamér Ferenczi
BPBernadett Pintér-Kübler
Bernadett Pintér-Kübler
LGLaura L. González-Martín
Laura L. González-Martín
MLM. Carmen Lasheras
M. Carmen Lasheras
Cristina NúñezCristina Núñez
Cristina Núñez
Both the hypothalamus-pituitary-adrenal (HPA) axis and the extrahypothalamic brain stress system are key elements of the neural circuitry that regulates the negative states during abstinence from chronic drug exposure. Orexins have recently been hypothesized to modulate the extended amygdala and to contribute to the negative emotional state associated with dependence. This study examined the impact of chronic morphine and withdrawal on the lateral hypothalamic (LH) orexin A (OXA) gene expression and activity as well as OXA involvement in the brain stress response to morphine abstinence. Male Wistar rats received chronic morphine followed by naloxone to precipitate withdrawal. The selective OX1R antagonist SB334867 was used to examine whether orexins' activity is related to somatic symptoms of opiate withdrawal and alterations in HPA axis and extended amygdala in rats dependent on morphine. OXA mRNA was induced in the hypothalamus during morphine withdrawal, which was accompanied by activation of OXA neurons in the LH. Importantly, SB334867 attenuated the somatic symptoms of withdrawal, and reduced morphine withdrawal-induced c-Fos expression in the nucleus accumbens (NAc) shell, bed nucleus of stria terminalis, central amygdala and hypothalamic paraventricular nucleus, but did not modify the HPA axis activity. These results highlight a critical role of OXA signalling, via OX1R, in activation of brain stress system to morphine withdrawal and suggest that all orexinergic subpopulations in the lateral hypothalamic area contribute in this response.

29 January 2009 in Endocrinology
Verified
Journal Article
Open access
PDF file
Cristina NúñezCristina Núñez
Cristina Núñez
AFAnna Földes
Anna Földes
DPDomingo Pérez-Flores
Domingo Pérez-Flores
Jose Carlos Garcia-BorronJose Carlos Garcia-Borron
Jose Carlos Garcia-Borron
MLM. Luisa Laorden
M. Luisa Laorden
MMMaría Victoria Milanés
María Victoria Milanés
Chronic opiate exposure induces neurochemical adaptations in the noradrenergic system. Enhanced responsiveness of the hypothalamo-pituitary-adrenal axis after morphine withdrawal has been associated with hyperactivity of ascending noradrenergic input from the nucleus of the solitary tract (NTS-A2) cell group to the hypothalamic paraventricular nucleus (PVN). This study addressed the role of morphine withdrawal-induced corticosterone (CORT) release in regulation of tyrosine hydroxylase (TH), the rate-limiting enzyme of catecholamine biosynthesis in adrenalectomized (ADX) rats supplemented with low CORT pellet (ADX plus CORT). Present results show that in sham-ADX rats, noradrenergic neurons in the NTS-A2 became activated during morphine withdrawal, as indicated by increased TH mRNA expression. However, this induction of TH expression is not detected in ADX plus CORT rats that are unable to mount CORT secretory response to morphine withdrawal. Total TH protein levels were elevated in the NTS-A2 from sham-operated rats during morphine dependence and withdrawal, whereas we did not find any alteration in ADX plus CORT animals. Furthermore, high levels of TH phosphorylated (activated) at Ser31 (but not at Ser40) were found in the A2 area from sham-morphine withdrawn rats. Consistent with these effects, we observed an increase in the enzyme activity of TH in the PVN. However, induction of morphine withdrawal to ADX plus CORT animals did not alter the phosphorylation (activation) of TH in NTS-A2 and decreased TH activity in the PVN. These results suggest the existence of a positive reverberating circle in which elevated glucocorticoids during morphine abstinence play a permissive role in morphine withdrawal-induced activation of noradrenergic pathway innervating the PVN.